A detailed history of Commerzbank Aktiengesellschaft transactions in Boston Scientific Corp stock. As of the latest transaction made, Commerzbank Aktiengesellschaft holds 8,480 shares of BSX stock, worth $629,724. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,480
Previous 8,077 4.99%
Holding current value
$629,724
Previous $554,000 18.05%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$67.33 - $77.71 $27,133 - $31,317
403 Added 4.99%
8,480 $654,000
Q1 2024

May 10, 2024

BUY
$57.6 - $68.62 $101,260 - $120,633
1,758 Added 27.82%
8,077 $554,000
Q4 2023

Feb 01, 2024

BUY
$48.64 - $57.81 $307,356 - $365,301
6,319 New
6,319 $366,000
Q1 2020

Apr 29, 2020

SELL
$25.83 - $45.71 $2.09 Million - $3.7 Million
-80,942 Closed
0 $0
Q4 2019

Jan 17, 2020

BUY
$37.87 - $45.37 $695,785 - $833,583
18,373 Added 29.36%
80,942 $3.66 Million
Q3 2019

Oct 17, 2019

BUY
$40.31 - $43.45 $253,267 - $272,996
6,283 Added 11.16%
62,569 $2.55 Million
Q2 2019

Jul 23, 2019

BUY
$34.91 - $42.98 $355,104 - $437,192
10,172 Added 22.06%
56,286 $2.42 Million
Q1 2019

May 13, 2019

SELL
$32.91 - $40.75 $232,772 - $288,224
-7,073 Reduced 13.3%
46,114 $1.77 Million
Q4 2018

Feb 06, 2019

BUY
$31.73 - $39.04 $724,173 - $891,009
22,823 Added 75.16%
53,187 $1.88 Million
Q3 2018

Nov 13, 2018

BUY
$32.83 - $38.63 $32,797 - $38,591
999 Added 3.4%
30,364 $1.17 Million
Q2 2018

Aug 10, 2018

SELL
$26.84 - $34.32 $63,798 - $81,578
-2,377 Reduced 7.49%
29,365 $960,000
Q1 2018

May 01, 2018

BUY
$25.2 - $28.54 $276,368 - $312,998
10,967 Added 52.79%
31,742 $867,000
Q4 2017

Jan 26, 2018

BUY
$24.79 - $29.8 $129,131 - $155,228
5,209 Added 33.46%
20,775 $515,000
Q3 2017

Nov 13, 2017

BUY
$26.26 - $29.17 $408,763 - $454,060
15,566
15,566 $454,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $106B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Commerzbank Aktiengesellschaft Portfolio

Follow Commerzbank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

News

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.